|
C22ORF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.095030E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.547990E-01 |
| Normal-vs-Stage2 |
2.128400E-01 |
| Normal-vs-Stage3 |
2.681600E-01 |
| Normal-vs-Stage4 |
1.497970E-01 |
| Stage1-vs-Stage2 |
6.608600E-01 |
| Stage1-vs-Stage3 |
9.021600E-01 |
| Stage1-vs-Stage4 |
6.397000E-01 |
| Stage2-vs-Stage3 |
6.106400E-01 |
| Stage2-vs-Stage4 |
9.575200E-01 |
| Stage3-vs-Stage4 |
6.193200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.483400E-01 |
| Normal-vs-AfricanAmerican |
1.136410E-01 |
| Normal-vs-Asian |
2.318000E-01 |
| Caucasian-vs-AfricanAmerican |
1.900970E-01 |
| Caucasian-vs-Asian |
5.596400E-01 |
| AfricanAmerican-vs-Asian |
4.492600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.508000E-01 |
| Normal-vs-Female |
1.937230E-01 |
| Male-vs-Female |
7.850200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.369200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.869800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.774000E-02 |
| Normal-vs-Age(81-100Yrs) |
6.233800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.071800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.668600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.965800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.526400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.987000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.571400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.971240E-01 |
| Classical-VS-Follicular |
7.99800000000905E-05 |
| Classical-VS-Other |
7.865800E-02 |
| Classical-VS-Normal |
6.129600E-01 |
| Tall-VS-Follicular |
7.617100E-04 |
| Tall-VS-Other |
2.744500E-02 |
| Tall-VS-Normal |
3.986600E-01 |
| Follicular-VS-Other |
8.442800E-01 |
| Follicular-VS-Normal |
2.977400E-04 |
| Other-VS-Normal |
3.707700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.443700E-02 |
| Normal-vs-N1 |
4.491700E-02 |
| N0-vs-N1 |
5.439600E-01 |
|
|
